Standard NAD+ supplements rely on passive diffusion and specialized transporters for cellular entry
A population-average curve obtained by taking the mean , and across diabetic patients (bold curve in Figure 3) reveals quantal characteristics of the average GSH response to glucose: Hyperglycemia is associated with a shallow low-glutathione phase
Results are very patient-dependent, so we cant guarantee a specific outcome
It highlights its immunomodulatory, antioxidant, antimicrobial, antifungal, anticancer (skin, oral, lung, breast, cervical), antidepressant, anxiolytic, cardiovascular, chemopreventive, and anti-angiogenic properties
monitoring recommended in polypharmacy settings NAD+ has the clear safety advantage through human trial data across diverse populations, though long-term safety remains unestablished for both interventions